Join us in 2020 for Europe’s most exciting Advanced Therapies and Cord Blood Event. Across the three days meet new contacts, investigate new processes and build your network.


Advanced Therapies Tracks

Pricing and Market Access

• Regulation & Reimbursement
• Investment & funding strategies
• Clinical development and product release

Gene Editing

• Delivering autologous and allogenic CAR-T
• Moving from phase II – phase III
• Clinical development
• Autologous
• Allogenic
• Scaling up production
• Moving beyond CAR-T towards gene editing and microbiome treatments



• Ensuring clinical success and safety
• Immuno-oncology
• Regulation, reimbursement and market access
• Non-oncology

Cell Therapy

• Regulation
• Mechanism of action
• Stem cells and regenerative medicine
• iPSCs vs MSCs


Research & Development

• New clinical data Safety and efficacy
• New methods and strategies for success


Gene Therapy

• New preclinical and clinical data
• Safety and efficacy
• New methods and strategies for success


Stem Cells & Regen Med

• Expansion and engraftment
• Donation and Education
• Banking
• From lab to clinic
• Haplo vs cord blood


Gene Modified Cell Therapy 

• Facility design
• Successful tech transfer
• Keeping a clean room
• De-risking supply chain


Viral Vector Manufacture

• Process development: Scale up and scale out
• GMP Manufacturing & formulation of finished product
• Non-clinical development programmes


Patient Delivery 

• Sample collection, handling and logistics
• Regulation
• Product distribution
• Cryo-shipping strategies
• Manufacturing automation and cell therapy
• Reimbursement and integrated care


Pitch & Partner






“I wanted to thank you for giving me the opportunity to be a part of this wonderful conference. I enjoyed the presentations very much and I hope I gave a little back in the round tables and the panels I participated in.”


VP Development, Pluristem Therapeutics